Adenosine → 2'-Deoxy-2'-fluoroguanosine

HRID 37068

Reaktionsgleichung

Reaktionsgleichung von HRID 37068
[NH2:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[C@@H:11]2[O:16][C@H:15]([CH2:17][OH:18])[C@@H:13]([OH:14])[C@H:12]2[F:19])=[C:4](N)[N:3]=1.[C@@H]1(N2C3N=CN=C(N)C=3N=C2)O[C@H](CO)[C@@H](O)[C@H]1[OH:23]>O>[F:19][C@@H:12]1[C@H:13]([OH:14])[C@@H:15]([CH2:17][OH:18])[O:16][C@H:11]1[N:8]1[CH:7]=[N:6][C:5]2[C:4](=[O:23])[NH:3][C:2]([NH2:1])=[N:10][C:9]1=2

Komponenten

4

Reaktionsbedingungen

Temperatur
4 °C

Versuchsvorschrift

2,6-Diamino-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purine (0.20 g, 0.64 mmole), prepared as in Example 6, was dissolved in 15 ml of water. Calf intestinal adenosine deaminase (4 I.U., Boehringer Mannheim) was added and the solution incubated at 37° for 4 days. The solution was cooled to 4° C. After 3 hrs, the suspension was filtered to remove the first batch of product crystals. The volume of the filtrate was reduced under vacuum and the suspension cooled to 4° C. The suspension was filtered to remove the second batch of product crystals. The batches of product crystals were combined, suspended in water and lyophilized to obtain title compound that analyzed as a 1.3 hydrate.

Aufarbeitung

  1. waitAfter 3 hrs
  2. filtrationthe suspension was filtered
  3. customto remove the first batch of product crystals
  4. temperaturethe suspension cooled to 4° C
  5. filtrationThe suspension was filtered
  6. customto remove the second batch of product crystals

Quellen und Nachweise

ORD-Eintrag
ord-7aa613c29b004721978c946d018d6d83
Quelldatensatz
uspto-grants-1995_05
Patentnummer
US05420115

Verknüpfte Notizen

Wird geladen…